Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 31;17(8):1008.
doi: 10.3390/ph17081008.

Long Non-Coding H19 in Lymphocytes: Prognostic Value in Acute Ischemic Stroke Patients

Affiliations

Long Non-Coding H19 in Lymphocytes: Prognostic Value in Acute Ischemic Stroke Patients

Liyuan Zhong et al. Pharmaceuticals (Basel). .

Abstract

Acute ischemic stroke (AIS) is a cerebrovascular disease that seriously affects the physical and mental health and quality of life of patients. However, there is a lack of reliable prognostic prediction methods. The main objective of this study was to investigate the prognostic value of long non-coding RNA (lncRNA) H19 in lymphocytes of patients with AIS, and to construct a prognostic prediction model for AIS including lncRNA H19 in lymphocytes, which would provide new ideas for the prognostic evaluation of AIS. Poor prognosis was defined when the patient's modified Rankin scale (mRS) score at 3 months after AIS onset was greater than 2. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure the level of lncRNA H19 in lymphocytes. Spearman correlation analysis revealed a positive correlation between lncRNA H19 and mRS score at 3 months after AIS onset (r = 0.1977, p = 0.0032), while lncRNA H19 was negatively correlated with white blood cells counts, lymphocytes counts, and neutrophils counts. Logistic regression analysis identified lncRNA H19 as an independent predictor of poor prognosis (OR = 3.062 [1.69-5.548], p < 0.001). Moreover, a nomogram prediction model incorporating lncRNA H19 in lymphocytes demonstrated effective discrimination, calibration, and clinical applicability in predicting AIS outcomes. The findings suggest that lncRNA H19 in lymphocytes could be a valuable prognostic indicator and a potential pharmacological target for AIS patients, and might be a novel pathway for enhanced prognostic evaluation and targeted therapeutic strategies.

Keywords: AIS; lncRNA H19; lymphocytes; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Correlation of H19 level in lymphocytes with counts of white blood cells, neutrophils, and lymphocytes. (A) Correlation between H19 level in lymphocytes and white blood cell counts; (B) correlation between H19 level in lymphocytes and neutrophils counts; (C) correlation between H19 level in lymphocytes and lymphocytes counts.
Figure 2
Figure 2
Correlation between H19 level in lymphocytes and prognosis in AIS patients. (A) Correlation between H19 level in lymphocytes and 3-month mRS scores. (B) Expression levels of H19 in lymphocytes of AIS patients with good prognosis (mRS 0–2) and with poor prognosis (mRS 3–6). AIS: acute ischemic stroke. mRS: modified Rankin scale. **** p < 0.0001.
Figure 3
Figure 3
Forest plot for multivariate logistic regression analysis. OR—odds ratio; NLR—neutrophil-to-lymphocyte ratio; NIHSS—National Institutes of Health stroke scale; EMT—endovascular mechanical thrombectomy.
Figure 4
Figure 4
The creation and assessment of the nomogram. (A) The nomogram for predicting 3-month poor prognosis in AIS patients; (B) ROC curves of the nomogram; (C) calibration curves of the nomogram; (D) DCA analysis of the nomogram. EMT—endovascular mechanical thrombectomy; NLR—neutrophil-to-lymphocyte ratio.

References

    1. Yao G.Y., Zhu Q., Xia J., Chen F.J., Huang M., Liu J., Zhou T.T., Wei J.F., Cui G.Y., Zheng K.Y., et al. Ischemic postconditioning confers cerebroprotection by stabilizing VDACs after brain ischemia. Cell Death Dis. 2018;9:1033. doi: 10.1038/s41419-018-1089-5. - DOI - PMC - PubMed
    1. Feigin V.L., Owolabi M.O. Pragmatic solutions to reduce the global burden of stroke: A World Stroke Organization-Lancet Neurology Commission. Lancet Neurol. 2023;22:1160–1206. doi: 10.1016/S1474-4422(23)00277-6. - DOI - PMC - PubMed
    1. Li H., Cai H., Lou X., Yu M., Li Z. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis. J. Cell. Mol. Med. 2022;26:475–490. - PMC - PubMed
    1. Dharap A., Nakka V.P., Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke. 2012;43:2800–2802. doi: 10.1161/STROKEAHA.112.669465. - DOI - PMC - PubMed
    1. Dykstra-Aiello C., Jickling G.C., Ander B.P., Shroff N., Zhan X., Liu D., Hull H., Orantia M., Stamova B.S., Sharp F.R. Altered expression of long noncoding RNAs in blood after ischemic stroke and proximity to putative stroke risk loci. Stroke. 2016;47:2896–2903. doi: 10.1161/STROKEAHA.116.013869. - DOI - PMC - PubMed

LinkOut - more resources